Published on in Vol 25 (2023)
1 Regional Medical Affairs, Pfizer Corporation Hong Kong Limited, Hong Kong, China (Hong Kong)
2 Executive Office, Transform Medical Communications Limited, Wanganui, New Zealand
3 Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
4 Medical Affairs Office, National Taiwan University Cancer Center, Taipei, Taiwan
*these authors contributed equally